Express News | Singular Genomics Regains Nasdaq Compliance

BenzingaJul 15 16:06 ET

Express News | Singular Genomics Regains Compliance With Nasdaq Minimum Bid Price Requirement

ReutersJul 15 16:05 ET

Goldman Sachs Adjusts Price Target on Singular Genomics Systems to $6.50 From $22.50, Maintains Neutral Rating

11:15 AM EDT, 07/09/2024 (MT Newswires) -- Goldman Sachs Adjusts Price Target on Singular Genomics Systems to $6.50 From $22.50, Maintains Neutral RatingPrice: 7.55, Change: -0.10, Percent Change: -1.

MT NewswiresJul 9 11:15 ET

Goldman Sachs Maintains Neutral on Singular Genomics Sys, Lowers Price Target to $6.5

Goldman Sachs analyst Matthew Sykes maintains Singular Genomics Sys (NASDAQ:OMIC) with a Neutral and lowers the price target from $22.5 to $6.5.

BenzingaJul 9 10:45 ET

Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

BenzingaJun 26 08:55 ET

Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending

BenzingaJun 25 19:50 ET